NeuroBo Pharmaceuticals, Inc (NRBO)

Etorro trading 970x250

About NeuroBo Pharmaceuticals, Inc

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative and cardiometabolic diseases. Its therapeutics programs include NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of protein; and Gemcabene, which is focused on developing and commercializing therapies for the treatment of dyslipidemia. NeuroBo Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Boston, Massachusetts. Address: 200 Berkeley Street, Boston, MA, United States, 02116

NeuroBo Pharmaceuticals, Inc News and around…

Latest news about NeuroBo Pharmaceuticals, Inc (NRBO) common stock and company :

First Week of June 2022 Options Trading For NeuroBo Pharmaceuticals (NRBO)
15 Oct, 2021 FinancialContent

Investors in NeuroBo Pharmaceuticals Inc (NRBO) saw new options become available this week, for the June 2022 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 245 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

Best Penny Stocks to Buy Right Now? Here’s 3 For Your Watchlist in October
14 Oct, 2021 FinancialContent
Accelerating R&D Activities in Breast Cancer Therapy Market Fueling Optimism for Development of Advanced Treatments
14 Oct, 2021 FinancialContent
12 Health Care Stocks Moving In Thursday's Pre-Market Session
14 Oct, 2021 FinancialContent

Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock increased by 34.63% to $12.71 during Thursday's pre-market session. ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
13 Oct, 2021 FinancialContent

Gainers Statera BioPharma (NASDAQ:STAB) shares increased by 16.92% to $3.16 during Wednesday's regular session. The ...

Hot Penny Stocks: Why NEW, ARDX, WTRH, GSAT and NRBO Are Moving Today
13 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips There's loads of hot penny stocks worth checking in on today and we're taking a look at what some of the top movers are doing! The post Hot Penny Stocks: Why NEW, ARDX, WTRH, GSAT and NRBO Are Moving Today appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
13 Oct, 2021 FinancialContent

Gainers Revance Therapeutics (NASDAQ:RVNC) stock moved upwards by 17.79% to $24.09 during Wednesday's pre-market ...

NeuroBo Pharmaceuticals Announces Positive Recommendation from Independent Data Safety Monitoring Committee of Phase 2/3 Clinical Trial of ANA001 in Hospitalized Patients with Moderate to Severe COVID-19
13 Oct, 2021 Yahoo! Finance

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying therapies for viral, neuropathic and neurodegenerative diseases, today announced that an independent Data Monitoring Committee (DMC) reviewed safety data from 36 patients treated in the Phase 2/3 clinical trial of NeuroBo's lead drug candidate, ANA001, a proprietary oral niclosamide formulation being developed as a potential treatment for COV

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
12 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
08 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
07 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
06 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

NeuroBo Pharmaceuticals Closes $14 Million Registered Direct Offering
05 Oct, 2021 Yahoo! Finance

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for viral, neuropathic and neurodegenerative diseases, today announced the closing of its previously announced registered direct offering of 4,307,693 shares of the Company's common stock, at a purchase price of $3.25 per share. In a concurrent private placement, the Company issued to the investors in the registered direct offering

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
05 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

54 Biggest Movers From Friday
04 Oct, 2021 FinancialContent

Check out these big penny stock gainers and losersLosers Spire Global, Inc.. (NYSE: SPIR) shares fell 43.3% to ...

Mid-Afternoon Market Update: Nasdaq Rises Over 100 Points; Biomerica Shares Spike Higher
01 Oct, 2021 FinancialContent

Toward the end of trading Friday, the Dow traded up 1.49% to 34,346.53 while the NASDAQ rose 0.75% to 14,556.92. The S&P also rose, ...

Friday Sector Laggards: Biotechnology, Diagnostics
01 Oct, 2021 FinancialContent

In trading on Friday, biotechnology shares were relative laggards, down on the day by about 1%. Helping drag down the group were shares of Neurobo Pharmaceuticals, off about 29% and shares of Vir Biotechnology off about 21.8% on the day.

12 Health Care Stocks Moving In Friday's Intraday Session
01 Oct, 2021 FinancialContent

Gainers Biomerica (NASDAQ:BMRA) stock moved upwards by 39.33% to $6.27 during Friday's regular session. As of 12:30 ...

NeuroBo Pharmaceuticals Announces $14 Million Registered Direct Offering
01 Oct, 2021 Yahoo! Finance

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for viral, neuropathic and neurodegenerative diseases, today announced that it has entered into a definitive agreement with several institutional investors for the purchase and sale in a registered direct offering of 4,307,693 shares of the Company's common stock, at a purchase price of $3.25 per share. In a concurrent private plac

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
28 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We're starting off Tuesday with a breakdown of the biggest pre-market stock movers rising and falling this morning. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

18 Stocks Moving in Tuesday's Pre-Market Session
28 Sep, 2021 FinancialContent

Gainers Planet Green Holdings Corp. (NYSE: PLAG) rose 40% to $1.61 in pre-market trading as Form 4 showed CEO Bin Zhou bought ...

7 Biotech Stocks to Buy That Have Millionaire-Maker Potential
10 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips This sector is always a risky area to gamble in. If you have the stomach for it, however, these biotech stocks could see massive gains. The post 7 Biotech Stocks to Buy That Have Millionaire-Maker Potential appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Here's What NeuroBo Pharmaceuticals, Inc.'s (NASDAQ:NRBO) Shareholder Ownership Structure Looks Like
03 Sep, 2021 Yahoo! Finance

The big shareholder groups in NeuroBo Pharmaceuticals, Inc. ( NASDAQ:NRBO ) have power over the company. Institutions...

12 Health Care Stocks Moving In Thursday's Intraday Session
02 Sep, 2021 FinancialContent

Gainers Innate Pharma (NASDAQ:IPHA) shares rose 18.22% to $4.28 during Thursday's regular session. As of 12:30 EST, ...

12 Health Care Stocks Moving In Wednesday's After-Market Session
25 Aug, 2021 FinancialContent

Gainers Ascendis Pharma (NASDAQ:ASND) stock moved upwards by 20.07% to $148.1 during Wednesday's after-market session. This security ...

12 Health Care Stocks Moving In Tuesday's After-Market Session
17 Aug, 2021 FinancialContent

Gainers Celularity (NASDAQ:CELU) shares rose 7.0% to $7.33 during Tuesday's after-market session. The market ...

NeuroBo Pharmaceuticals Reports Second Quarter 2021 Financial Results
16 Aug, 2021 Yahoo! Finance

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying therapies for viral, neuropathic and neurodegenerative diseases, today announced financial results for the second quarter ended June 30, 2021.

61 Biggest Movers From Yesterday
22 Jul, 2021 FinancialContent

Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares surged 159.2% to close at $5.34 on Wednesday after the company received a ...

38 Stocks Moving In Wednesday's Mid-Day Session
21 Jul, 2021 FinancialContent

Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares jumped 218.7% to $6.57 after the company received a $28.3 million purchase ...

Mid-Morning Market Update: Markets Open Higher; Coca-Cola Tops Q2 Views
21 Jul, 2021 FinancialContent

Following the market opening Wednesday, the Dow traded up 0.62% to 34,727.53 while the NASDAQ rose 0.40% to 14,557.04. The S&P also ...

NeuroBo Pharmaceuticals, Inc (NRBO) is a NASDAQ Common Stock listed in , ,

970x250